Home » Volumes » Volume 51 April/June 2018 » Molecular diagnosis of cutaneous leishmaniasis in an endemic area of Acre State in the Amazonian Region of Brazil

Molecular diagnosis of cutaneous leishmaniasis in an endemic area of Acre State in the Amazonian Region of Brazil

Thais de Araujo-Pereira1 Daniela de Pita-Pereira1 Regina Barbosa Moreira2 Tainah Silva-Galdino2 Márcia P. de Oliveira Duarte2 Reginaldo Peçanha Brazil3 Constança Britto1

1Laboratório de Biologia Molecular e Doenças Endêmicas, Instituto Oswaldo Cruz/Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brasil. 2Laboratório Interdisciplinar de Pesquisas Médicas, Instituto Oswaldo Cruz/Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brasil. 3Laboratório de Doenças Parasitárias, Instituto Oswaldo Cruz/Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brasil.

DOI: 10.1590/0037-8682-0232-2017

Leishmaniasis is a tropical disease caused by protozoan parasites of the genus Leishmania and is characterized by a broad range of clinical manifestations classified as cutaneous and visceral leishmaniasis


ABSTRACT

INTRODUCTION

This study proposes to identify the Leishmania species found in the skin lesions of cutaneous leishmaniasis (CL) patients from Brasiléia municipality (Acre).

METHODS

Skin biopsy imprints or biopsy fragments were assayed via kDNA-PCR/RFLP and FRET-real-time PCR.

RESULTS

Of individuals with suspected CL, 18 were positive for Leishmania kDNA. Leishmania (Viannia) braziliensis (61.1%) and Leishmania (Viannia) guyanensis (5.5%) were identified in the positive samples.

CONCLUSIONS

These results are congruent with the previous reports in Acre and Bolivia, revealing L. braziliensis as the most prevalent species. L. guyanensis identification also corroborates with the epidemiology of the disease in the Amazon Basin.

Keywords: Cutaneous leishmaniasis; Molecular diagnosis; Acre State


Leishmaniasis is a tropical disease caused by protozoan parasites of the genus Leishmania and is characterized by a broad range of clinical manifestations classified as cutaneous and visceral leishmaniasis1. Cutaneous leishmaniasis (CL) is caused mainly by Leishmania (Leishmaniamajor and Leishmania (Leishmaniatropica in the Old World, and by parasites of the Leishmania (Leishmaniamexicana and Leishmania (Vianniabraziliensiscomplexes in Central and South America2. Epidemiological records indicate that CL is distributed worldwide, affecting at least 12 million people in 98 countries, with 90% of all cases occurring in only seven countries, including two from South America: Brazil and Peru3. In Brazil, CL is an important public health concern with 21,161 reported cases in 2015, the majority (69%) of these being in the Amazonian states4.

In the New World, CL is a zoonotic disease caused by a variety of Leishmania species, transmitted to humans by female sandflies belonging to the Lutzomyia genus. Currently, CL is considered an emergent and re-emergent disease, and there is an increasing concern regarding the adaptation of its parasite transmission cycle to urban environments. In Brazil, the expansion of CL throughout the Amazon region appears to be facilitated by the development of agricultural frontiers, the emergence of mining areas, and the establishment of new urban centers in environments susceptible to disease transmission5. The Brazilian Amazonian State of Acre is an example of the driving effects of human activities on the epidemiology of leishmaniasis. Recent records from this state indicate that 3,538 confirmed CL cases were reported between 2010 and 2013. Moreover, up to 1,215 cases were reported exclusively in the municipality of Brasiléia, located on the Brazil/Peru/Bolivia tri-border, which stands out as the municipality with the second highest number of CL cases in Acre State4. This ongoing transmission in urban and peri-urban settings reinforces the need to better characterize the epidemiological patterns of CL in the state. A few studies have been conducted in the area, most of them in Rio Branco, the capital of Acre68. Furthermore, the difficulty of providing an accurate diagnosis may result in an underestimation of the incidence of leishmaniasis in Acre.

In this study, we aimed to assess the epidemiology of CL in the municipality of Brasiléia by applying molecular tools for the detection and genotyping of the existing Leishmania species. Our results will provide insights into the transmission of species responsible for leishmaniasis and could contribute to better surveillance and control strategies in the area.

In order to explore the epidemiology of CL in Brasiléia, we conducted a prospective study at the Brasiléia Health Center from September 2013 to February 2015. All patients provided written informed consent for collection of samples and subsequent analysis.

The City of Brasiléia is located in the Northern State of Acre, Brazil [11°00′S 68°44′W] (Figure 1) and had a population of 23,378 inhabitants in 2015. The region exhibits an equatorial tropical climate with annual temperatures between 22˚C and 33˚C and annual precipitation around 1,900mm.

All patients reside in Brasiléia, Acre and attended to the Fernando Azevedo Correia Center of Health. They presented with skin lesions with characteristics of CL and were submitted to Montenegro skin test. Between September 2013 and February 2015, patients with suspected or confirmed CL were invited to participate in the study after providing signed, written informed consent. Participants provided sociodemographic information, including sex, age and location (rural or urban area) during the medical appointment. In addition, skin biopsy imprints on filter paper (FTA® cards) were collected from the lesions, and in some cases, biopsy fragments were obtained from the border of lesions after administering a local anesthetic [2% lidocaine (xylocaine)]. These samples were stored in liquid nitrogen until processing. All recommended measures (e.g. the use of individual disposable blades for filter paper cutting and careful individual packaging of material) were taken to prevent cross contamination.

Deoxyribonucleic acid (DNA) was extracted from FTA® cards (skin biopsy imprints) and biopsy fragments as described by Marques et al.9. The kinetoplast DNA (kDNA)-polymerase chain reaction (PCR) was performed as previously described10. Following amplification, kDNA products were digested with HaeIII (Invitrogen®, USA) for 3h at 37°C, in accordance with the manufacturer’s recommendations, and the resulting digestion fragments were analyzed on a 12% silver-stained polyacrylamide gel. A fluorescent resonance energy transfer (FRET) real-time PCR based on Leishmania species-specific DNA polymorphisms in the genes encoding mannose phosphate isomerase (MPI) and 6-phosphoglucanate dehydrogenase (6PGD) was carried-out to support the identification of the Leishmania species in the kDNA-positive samples11.

Twenty-two patients who provided clinical and sociodemographic information and presented positive results in the Montenegro skin test were included (Table 1). Of those, 18 lived in rural areas (transversely situated along the Federal BR317 Trans Pacific highway, named Ramal or Ramais, based on the distance from the center of Brasiléia); three patients were from urban areas (center of Brasiléia), and one represented an imported case from Cobija, Pando District, in Bolivia (Figure 1 and Table 1). Most patients from rural areas (n=12) resided in isolated reserves located far away within the Ramais, in dense forest sites. The remaining patients from rural areas lived in kilometer 4 – Ramal do Polo (n=5) and kilometer 5 – Ramal do Jarinal (n=1), less isolated than the reserves, but still close to the dense forest (Figure 1). The houses were simple dwellings without basic sanitation, with many peridomiciliary animals, providing a favorable environment for the attraction and multiplication of insect vectors.

TABLE 1: Characteristics of the study group and diagnostic results of skin biopsy imprints and biopsy fragments from cutaneous lesions of patients with positive Montenegro test. 

Patients
Sampling Variable
sex age area
male female 0-7 8-14 15-21 22-30 rural urban imported case
10 12 2 6 7 7 18 3 1
Characteristic Distribution Unique 7 9 1 5 5 5 14 1 1
s of the lesions Multiple (2-7) 3 3 1 1 2 2 4 2
Borders Regular 5 4 1 2 2 4 8 1
Irregular 5 8 1 4 5 3 10 2 1
Diameter cm 1-7 0.5-4 1-4 1-3 1-4 1-7 0.5-4 1.5-7 2
Mean duration* Days 15-120 30-120 15-120 30-120 15-120 30-60 15-120 60-120 30
Localization Upper limbs X X X X
Lower limbs X X X X X X X X X
Thorax X X X
Face X X X X
Diagnostic results Positive for KDNA** 7 11 1 6 6 5 14 3 1
Leishmania species L.bra 3 8 3 5 3 10 1
L.guy 1 1 1
NI 4 2 1 2 1 2 3 3

Lbra: Leishmania braziliensisLguy: Leishmania guyanensisNI: not identified; cm: centimeters; kDNA:kinetoplast deoxyribonucleic acid. *Based on the Montenegro skin test. **Positive samples for the presence of Leishmania kDNA.

FIGURE 1: Brasiléia municipality, State of Acre, Brazil. Geographic distribution of the patients with clinically suspected cutaneous leishmaniasis from Brasiléia. Rural areas (transversely located along the Trans Pacific Federal Highway BR 317): 1. Kilometer 4, Ramal do Polo2. Kilometer 5, Ramal do Jarinal and Filipinas extractive reserve3. Kilometer 18, Guanabara extractive reserve4. Kilometer 52, São Cristovão extractive reserve5. Kilometer 59, AputiTabatingaNova LindaEtelhi and Nova Pinda extractive reserves6. Kilometer 67, Guanabara extractive reserve7. Kilometer 84, Guanabara and Amapá extractive reserves. Urban area: 8. Center of Brasiléia City. Imported case: 9. Cobija, Pando district – Bolivia. 

The patients positive for the Montenegro skin test presented with lesions that were clinically characterized as simple or multiple ulcer-crusted lesions with 59% of them presenting irregular borders and were mostly observed on the lower limbs (Table 1). Detection of Leishmania genus parasites via kDNA-PCR resulted in 18 positive samples out of 22 patients with clinically suspected CL. The 4 negative samples (three biopsy fragments and one imprint) were obtained from individuals living in kilometer 4 – Ramal do Polo (rural area; 3 males and 1 female) (Table 1). This negative result may probably be due to the lapse of time between lesion formation and the collection of clinical material, considering that parasite detection becomes more difficult as the number of parasites in the lesion decreases with the progression of the chronic granulomatous process12. Following HaeIII digestion of the kDNA amplified products from 18 positive samples, the restriction profile corresponding to L. (V.) braziliensis was identified in 11/18 samples (61.1%), namely the presence of two fragments of 40 and 80bp in 12% silver-stained acrylamide gel (data not shown).

FRET-based real-time PCR was used to confirm the identification of the species of Leishmania in the positive kDNA samples. This assay is based on the identification of mutations in the 6PGD and MPI genes, yielding distinct melting peaks that are used to differentiate between five Leishmania (Viannia) species11. The method detects down to 60fg of parasite DNA, which is equivalent to less than five parasites per reaction11Figure 2 shows an example of the results obtained by the coupled analysis of 6PGD and MPI loci. Three samples (II, VI and VIII) identified as L. (V.) braziliensis or Leishmania (Vianniaperuviana by the analysis of 6PGD gene (Figure 2A) were confirmed as L. (V.) braziliensis using the MPI locus (Figure 2B). The results of 6PGD analysis revealed infection by L. (V.) guyanensis (Floch 1954) in one sample (IX) (Figure 2A), whereas the same sample was identified as Leishmania (Vianniapanamensis or L. (V.) guyanensis through the dissociation profile of the MPI amplification products (Figure 2B). Using FRET real-time PCR, we were able to confirm L. (V.) braziliensis infection in 11 out of 18 samples, corroborating the results of HaeIII digestion of kDNA-amplified products (PCR-RFLP- Restriction Fragment Length Polymorphism). It also allowed the detection of L. (V.) guyanensis in one sample that did not exhibit a restriction profile congruent with L. (V.) braziliensis in the PCR-RFLP.

FIGURE 2: Example of melting curve analysis of FRET real-time PCR focusing on the 6PGD and MPI genes. Dotted lines represent cutaneous lesion samples from patients with suspected cutaneous leishmaniasis. Solid lines correspond to a set of New World Leishmania reference strains used as standard samples. Leishmania species were identified based on melting curves exhibiting the same dissociation temperature. AMelting curves corresponding to 6PGD-based amplification reactions. Samples from three patients (II, VI and VIII) were identified as \ braziliensis or L. (V.) peruviana, and one sample (IX) revealed the same melting temperature attributed to L. (V.) guyanensis reference strain. BMelting curves corresponding to MPI-based amplification reactions. Samples from patients (II, VI and VIII) were positioned at the same melting temperature corresponding to the L. (V.) braziliensis reference strain. Sample IX was identified as L. (V.) panamensis or L. (V.) guyanensisL. pan:Leishmania panamensisL. guy: Leishmania guyanensisL. lain: Leishmania lainsoniL. bra Leishmania braziliensisL. per:Leishmania peruvianaL. ama: Leishmania amazonensisL. mex: Leishmania mexicana; L. (V.): Leishmania (Viannia) FRET PCR: polymerase chain reaction; 6PGD: 6-phosphogluconate dehydrogenase; MPI: mannose phosphate isomerase. 

Infection with L. (V.) braziliensis in 61.1% of the patients suggests that this species is the main etiological agent responsible for CL cases in the municipality of Brasiléia, which agrees with previous findings in Rio Branco and other areas in Bolivia and Peru, bordering the State of Acre68,13. This result was expected, considering that L. (V.) braziliensis is recognized as the predominant species associated with the evolution to the mucosal form of CL in Latin America6. Herein, it is important to note that an imported case of L. (V.) braziliensis was identified in a Brazilian individual who became infected in Cobija, Pando district, a border City of Bolivia (Figure 1). In spite of the proximity between Cobija and Brasiléia, it is worth mentioning that the construction of the Pacific Highway BR317 promoted an increase in migration across the Brazil/Peru/Bolivia borders. Together with the growth of tourism, this may have had a role in the dissemination of CL in the region8.

We were able to identify L. (V.) guyanensis as the parasite responsible for the infection in a female 13 years old patient who resided in the Guanabara extractive reserve, kilometer 67). All Leishmania species implicated in the different clinical forms of CL in Brazil have been registered in the Amazon Basin2L. (V.) guyanensis has been well characterized in Acre, Amapá, Roraima and Pará14, and its main vector is Nyssomyia umbratilis, a sandfly recently observed at low density in Acre State8. In Peru, L. (V.) guyanensis is the third most common species associated with CL cases, following L. (V.) braziliensis and L. (V.) peruviana15.

In 6 samples positive for the presence of Leishmania kDNA, identification of the parasite species by both methods was unsuccessful, raising the possibility that other L. (Viannia) species could be circulating in Brasiléia, as observed in other regions of the Brazilian Amazon6,7. The HaeIII/kDNA restriction profile was inconclusive, and the samples were not amplified following the 6PGD/MPI real-time PCR analysis. A possible explanation could be the differences in copy number when comparing Leishmania kDNA minicircles and the 6PGD/MPI loci. The first are represented as thousands of copies per parasite mitochondrial genome, whereas the MPI and 6PGD are present as single copy genes, which could explain the higher sensitivity of kDNA-PCR assay over the approach used in FRET real-time PCR11. Further studies are necessary to improve the molecular identification of other Leishmania spp. implicated in the epidemiology of CL in the State of Acre.

In conclusion, in this study, most of the individuals with clinically suspected CL live in rural areas (81.8%), suggesting that these local cases are associated with activities in a forest environment, despite the finding of three individuals infected with L. (Viannia) living in urban areas in the center of Brasiléia. The positivity for Leishmania kDNA was higher in women (91.7%) than men, and the ages of infected individuals varied from 3 to 30 years old (Table 1).

The study performed in the municipality of Brasiléia revealed the predominance of L. (V.) braziliensis in cutaneous lesions of individuals with clinically suspected leishmaniasis, and that cutaneous disease is probably associated with rural lifestyle, particularly with the activities in rubber extraction reserve sites. From an epidemiological aspect, there are a few studies carried-out in Acre, and this study is the first conducted in Brasiléia district despite the small number of individuals studied. Further investigation is needed, taking into account the vectors, reservoirs, the incidence of cutaneous disease, and its respective etiological agents, as well as surveillance activities, and the control of leishmaniasis in the State of Acre.

Ethical considerations

The study was approved by the Ethical Committee of the Oswaldo Cruz [Instituto Oswaldo Cruz (IOC)], Oswaldo Cruz Foundation [Fundação Oswaldo Cruz (Fiocruz)], Rio de Janeiro (RJ), Brazil; protocol CAE02765312.7.0000.5248.

ACKNOWLEDGEMENTS

We would like to thank the Fernando Azevedo Correia Center of Health and in particular, Mrs. Solange Kurvski, who assisted patients with suspected leishmaniasis and those patients agreed to be included in the study. We are also grateful to Hugo Valdivia, Maxy B. De Los Santos, Erika Perez Velez, Andres G. Lescano and the United States Naval Medical Research Unit No. 6, Lima, Peru Departments of Parasitology for support with FRET real time PCR. Also, we would like to thank David M. Forrest for the English revision.

REFERENCES

1. Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet. 2005;366(9496):1561-77. [ Links ]

2. Lainson R. The Neotropical Leishmania species: a brief historical review of their discovery, ecology and taxonomy. Rev Pan-Amaz Saude. 2010;1(2):13-32. [ Links ]

3. World Health Organization (WHO). World Health Statistics 2015. Global Health Observatory (GHO) data. Available from: http://www.who.int/gho/publications/world_health_statistics/2015/en/ [ Links ]

4. Ministério da Saúde (MS). Sistema de Informação de Agravos de Notificação (SINAN). Brasilia: MS; 2015. Atualizado em 21 ago 2015; citado em 15 mai 2016. Disponível em: Disponível em: http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sinannet/cnv/ltaac.def [ Links ]

5. da Silva-Nunes M, Cavasini CE, Silva NS, Galati EAB. Epidemiologia da leishmaniose tegumentar e descrição das populações de flebotomíneos no município de Acrelândia, Acre, Brasil. Rev Bras de Epidemiol. 2008;11(2):241-51. [ Links ]

6. Tojal da Silva AC, Cupolillo E, Volpini AC, Almeida R, Romero GA. Species diversity causing human cutaneous leishmaniasis in Rio Branco, state of Acre, Brazil. Trop Med Int Health. 2006;11(9):1388-98. [ Links ]

7. Teles CBG, Medeiros JF, Santos APA, Freitas LAR, Katsuragawa TH, Cantanhêde LM, et al. Molecular characterization of American cutaneous leishmaniasis in the tri-border area of Assis Brasil, Acre State, Brazil. Rev Inst Med Trop Sao Paulo. 2015;57(4):343-7. [ Links ]

8. Teles CBG, dos Santos APA, Freitas RA., Oliveira AFJ, Ogawa GM, Rodrigues MS, et al. Phlebotomine sandfly (Diptera: Psychodidae) diversity and their Leishmania DNA in a hot spot of American Cutaneous Leishmaniasis human cases along the Brazilian border with Peru and Bolivia. Mem Inst Oswaldo Cruz. 2016;111(7):423-32. [ Links ]

9. Marques MJ, Volpini AC, Genaro O, Mayrink W, Romanha AJ. Simple form of clinical sample preservation and Leishmania DNA extraction from human lesions for diagnosis of American cutaneous leishmaniasis via polymerase chain reaction. Am J Trop Med Hyg. 2001;65(6):902-6. [ Links ]

10. Pirmez C, Trajano VS, Paes-Oliveira Neto M, da-Cruz AM, Gonçalves-da-Costa SC, Catanho M, et al. Use of PCR in diagnosis of human american tegumentary leishmaniasis in Rio de Janeiro, Brazil. J Clin Microbiol. 1999;37(6):1819-23. [ Links ]

11. Tsukayama P, Nunez JH, De Los Santos M, Soberon V, Lucas CM, Matlashewski G, et al. A FRET-based real-time PCR assay to identify the main causal agents of new world tegumentary leishmaniasis. PLoS Negl Trop Dis. 2013;7(1):e1956. [ Links ]

12. Murback NDN, Hans-Filho G, Nascimento RAF, Nakazato KRO, Dorval MEMC. American cutaneous leishmaniasis: clinical, epidemiological and laboratory studies conducted at a university teaching hospital in Campo Grande, Mato Grosso do Sul, Brazil. An Bras Dermatol. 2011;86(1):55-63. [ Links ]

13. Garcia AL, Tellez T, Parrado R, Rojas E, Bermudez H, Dujardin JC. Epidemiological monitoring of American tegumentary leishmaniasis: molecular characterization of a peridomestic transmission cycle in the Amazonian lowlands of Bolivia. Trans R Soc Trop Med Hyg. 2007;101:1208-13. [ Links ]

14. Guerra JA, Prestes SR, Silveira H, Coelho LI, Gama P, Moura A, et al. Mucosal leishmaniasis caused by Leishmania (Vianniabraziliensis and Leishmania (Vianniaguyanensis in the Brazilian Amazon. PLoS Negl Trop Dis . 2011;5(3):e980. [ Links ]

15. Lucas CM, Franke ED, Cachay MI, Tejada A, Cruz ME, Kreutzer RD, et al. Geographic distribution and clinical description of leishmaniasis cases in Peru. Am J Trop Med Hyg . 1998;59(2):312-7. [ Links ]

Financial support: This work was supported by CNPq (grant# 473859/2013-0) and Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ CNE E_05/2015). C. Britto and R.P. Brazil are research fellows of Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). D. Pita-Pereira is a FAPERJ postdoctoral fellow. FRET real time PCR was supported by the U.S. DoD Armed Forces Health Surveillance Center, Global Emerging Infections Surveillance and Response System (AFHSC/GEIS) project P0372_14_N6.

Received: October 10, 2017; Accepted: December 15, 2017

Corresponding author: Dr. Reginaldo Peçanha Brazil. e-mail: rpbrazil@ioc.fiocruz.br

Conflict of interest: The authors declare that there is no conflict of interest.